
Global Medical and Research Grade Collagen Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Medical and Research Grade Collagen market size will reach US$ million by 2031.
Collagen is a widely recognized biomaterial used in the pharmaceutical and health care industry. Collagen can be molded into artificial implants, and scaffolds for regeneration of tissues owing to their excellent biocompatibility. The use of collagen as excipients for various forms of drugs, and as vector systems for the controlled release of active substances in the pharmaceutical industry is expected to boost the sales of pharmaceutical and medical grade collagen. It is also used to enhance the elasticity and suppleness of the skin by repairing damage caused to skin by aging and exposure to sunlight and UV radiation. The primary medical application of collagen is catgut suture, which is derived from the intestinal collagen of bovines. Catgut sutures are used to promote wound healing.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Medical and Research Grade Collagen Industry Forecast” looks at past sales and reviews total world Medical and Research Grade Collagen sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical and Research Grade Collagen sales for 2025 through 2031. With Medical and Research Grade Collagen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical and Research Grade Collagen industry.
This Insight Report provides a comprehensive analysis of the global Medical and Research Grade Collagen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medical and Research Grade Collagen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical and Research Grade Collagen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical and Research Grade Collagen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical and Research Grade Collagen.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical and Research Grade Collagen market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gelatin
Hydrolyzed Collagen
Native Collagen
Others
Segmentation by Application:
Haemostats
Vascular Grafts
Tissue Scaffolds
Cartilage Repair
Wound Care
Bone Grafts
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DSM
Collagen Solutions Plc.
Croda International Plc.
Advanced Biomatrix Inc
Collagen Matrix, Inc.
Cologenesis Healthcare Pvt Ltd
Innocoll Holdings Plc
Integra LifeSciences Corporation
Nitta Gelatin, NA Inc.
Rousselot
Please note: The report will take approximately 2 business days to prepare and deliver.
Collagen is a widely recognized biomaterial used in the pharmaceutical and health care industry. Collagen can be molded into artificial implants, and scaffolds for regeneration of tissues owing to their excellent biocompatibility. The use of collagen as excipients for various forms of drugs, and as vector systems for the controlled release of active substances in the pharmaceutical industry is expected to boost the sales of pharmaceutical and medical grade collagen. It is also used to enhance the elasticity and suppleness of the skin by repairing damage caused to skin by aging and exposure to sunlight and UV radiation. The primary medical application of collagen is catgut suture, which is derived from the intestinal collagen of bovines. Catgut sutures are used to promote wound healing.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LPI (LP Information)' newest research report, the “Medical and Research Grade Collagen Industry Forecast” looks at past sales and reviews total world Medical and Research Grade Collagen sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical and Research Grade Collagen sales for 2025 through 2031. With Medical and Research Grade Collagen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical and Research Grade Collagen industry.
This Insight Report provides a comprehensive analysis of the global Medical and Research Grade Collagen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medical and Research Grade Collagen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical and Research Grade Collagen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical and Research Grade Collagen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical and Research Grade Collagen.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical and Research Grade Collagen market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gelatin
Hydrolyzed Collagen
Native Collagen
Others
Segmentation by Application:
Haemostats
Vascular Grafts
Tissue Scaffolds
Cartilage Repair
Wound Care
Bone Grafts
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
DSM
Collagen Solutions Plc.
Croda International Plc.
Advanced Biomatrix Inc
Collagen Matrix, Inc.
Cologenesis Healthcare Pvt Ltd
Innocoll Holdings Plc
Integra LifeSciences Corporation
Nitta Gelatin, NA Inc.
Rousselot
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
88 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Medical and Research Grade Collagen Market Size by Player
- 4 Medical and Research Grade Collagen by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Medical and Research Grade Collagen Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.